glp 1 agonist vs sglt2 inhibitor inhibitors or GLP-1 receptor agonists as second-line therapy in | VHRM Recommendations for SGLT2i versus GLP-1

A comparison of the various actions of these partner hormones in the T2DM patient is shown in Figure 2

Furthermore, hospital pharmacies often manage the dispensing of injectable medications requiring specific storage and handling, which is the case for many GLP-1 receptor agonists

Weighing risks and benefits of liraglutidethe FDA's review of a new antidiabetic therapy

European Heart Journal

If you have diabetes, your insurance is much more likely to cover it

Some investigators have proposed that GLP-1RAs improve myocardial insulin sensitivity, enhance glucose oxidation rates, reduce fatty acid oxidation, and thereby optimize myocardial energy metabolism, ultimately improving cardiac function.106 In a randomized controlled trial (RCT) conducted by Mikhail et al,106 semaglutide efficacy was evaluated in 616 patients with obesity-related heart failure and T2DM